Health, Medical & Pharma News - Updated Daily page 83

Blue Laser Vaporization Effective for Benign Prostatic Hyperplasia

Blue laser vaporization alleviates lower urinary tract symptoms while preserving sexual function in patients undergoing benign prostatic hyperplasia (BPH) surge

Semaglutide Ups Risk for Nonarteritic Anterior Ischemic Optic Neuropathy in Diabetes

For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy (NAION), according to a stu

Rural-Urban Differences Seen in Cardiometabolic Risk Factors, CVD

There are substantial rural-urban disparities in cardiometabolic risk factors and cardiovascular diseases among U.S. adults, according to a study published onli

Federal Funding Cuts Would 'Decimate' Medical Research, Expert Warns

Federal cuts to funding could decimate medical research in the United States, delaying cures and costing countless lives, according to a leader in cancer resear

Medicare Advantage Plans Squeezing Billions More From U.S. Government

Medicare Advantage plans are squeezing billions out of the federal government by billing more for patient care, a new study says. Medicare Advantage plans recei

CBD Could Calm Kids With Autism

A non-intoxicating extract of cannabis appears to help children and teenagers with autism, a new study says. Cannabidiol (CBD) enhanced social responsiveness, r

Pregnancy Might Offer Protection Against Long COVID

Pregnancy might offer women some protection from developing long COVID, a new study says. Women infected with COVID-19 during pregnancy were 14 to 30 less likel

RFK Jr. Wants CDC To Stop Recommending Fluoride in Drinking Water

U.S. Health Secretary Robert F. Kennedy Jr. says he will tell the U.S. Centers for Disease Control and Prevention (CDC) to stop recommending fluoride in drinkin

Liquid Egg Products Recalled Over Possible Bleach Contamination

More than 212,000 pounds of liquid egg substitutes have been recalled because they may be contaminated with a cleaning solution that contains bleach. Cargill Ki

Vividion Therapeutics Doses First Patient in Phase I Study of RAS-PI3Kα Inhibitor VVD-159642 for Treatment of Advanced Solid Tumors

San Diego, CA, USA, Berlin, Germany, April 3, 2025 Vividion Therapeutics, Inc. (Vividion) today announced that the first patient has been dosed in a Phase I cli

Pharmaceutical News and Articles